vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and SITE Centers Corp. (SITC). Click either name above to swap in a different company.

SITE Centers Corp. is the larger business by last-quarter revenue ($20.5M vs $14.7M, roughly 1.4× IRIDEX CORP). On growth, SITE Centers Corp. posted the faster year-over-year revenue change (-41.4% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -53.4%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

SITE Centers Corp. is a publicly traded real estate investment trust that invests in shopping centers. Founded in 1965 by Bert Wolstein, the company is headquartered in Beachwood, Ohio. As of December 31, 2019 the company owned interests in 170 shopping centers in the United States containing 57.0 million square feet and managed 13.2 million square feet for Retail Value Inc. Notable properties wholly owned by the company include Shopper's World in Framingham, Massachusetts. Its major tenants ...

IRIX vs SITC — Head-to-Head

Bigger by revenue
SITC
SITC
1.4× larger
SITC
$20.5M
$14.7M
IRIX
Growing faster (revenue YoY)
SITC
SITC
+28.4% gap
SITC
-41.4%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-53.4%
SITC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
SITC
SITC
Revenue
$14.7M
$20.5M
Net Profit
$134.4M
Gross Margin
37.2%
Operating Margin
Net Margin
657.2%
Revenue YoY
-69.7%
-41.4%
Net Profit YoY
2409.0%
EPS (diluted)
$2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
SITC
SITC
Q4 25
$14.7M
$20.5M
Q3 25
$12.5M
$27.1M
Q2 25
$13.6M
$33.5M
Q1 25
$11.9M
$42.6M
Q4 24
$12.7M
$34.9M
Q3 24
$11.6M
$61.0M
Q2 24
$12.6M
$87.5M
Q1 24
$11.8M
$94.1M
Net Profit
IRIX
IRIX
SITC
SITC
Q4 25
$134.4M
Q3 25
$-1.6M
$-6.2M
Q2 25
$-994.0K
$46.5M
Q1 25
$-1.7M
$3.1M
Q4 24
$-834.0K
Q3 24
$-1.9M
$323.0M
Q2 24
$-2.7M
$238.2M
Q1 24
$-3.5M
$-23.6M
Gross Margin
IRIX
IRIX
SITC
SITC
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
SITC
SITC
Q4 25
Q3 25
-11.3%
-22.0%
Q2 25
-6.9%
Q1 25
-1.7%
7.6%
Q4 24
-3.9%
Q3 24
-16.1%
Q2 24
-20.9%
Q1 24
-28.0%
-34.8%
Net Margin
IRIX
IRIX
SITC
SITC
Q4 25
657.2%
Q3 25
-12.6%
-22.7%
Q2 25
-7.3%
138.9%
Q1 25
-14.2%
7.2%
Q4 24
-6.6%
Q3 24
-16.7%
529.4%
Q2 24
-21.2%
272.2%
Q1 24
-29.5%
-25.0%
EPS (diluted)
IRIX
IRIX
SITC
SITC
Q4 25
$2.55
Q3 25
$-0.09
$-0.13
Q2 25
$-0.06
$0.88
Q1 25
$-0.10
$0.06
Q4 24
$-0.05
Q3 24
$-0.12
$6.07
Q2 24
$-0.16
$4.45
Q1 24
$-0.21
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
SITC
SITC
Cash + ST InvestmentsLiquidity on hand
$6.0M
$119.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$334.8M
Total Assets
$29.2M
$418.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
SITC
SITC
Q4 25
$6.0M
$119.0M
Q3 25
$5.6M
$128.2M
Q2 25
$6.8M
$153.8M
Q1 25
$7.2M
$58.2M
Q4 24
$2.4M
$54.6M
Q3 24
$3.9M
$1.1B
Q2 24
$4.1M
$1.2B
Q1 24
$5.4M
$551.3M
Total Debt
IRIX
IRIX
SITC
SITC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
SITC
SITC
Q4 25
$334.8M
Q3 25
$4.7M
$308.3M
Q2 25
$6.1M
$486.7M
Q1 25
$852.0K
$519.6M
Q4 24
$2.1M
$516.7M
Q3 24
$2.6M
$2.7B
Q2 24
$4.2M
$2.3B
Q1 24
$6.5M
$2.1B
Total Assets
IRIX
IRIX
SITC
SITC
Q4 25
$29.2M
$418.7M
Q3 25
$28.4M
$654.0M
Q2 25
$31.6M
$959.0M
Q1 25
$34.2M
$929.8M
Q4 24
$29.1M
$933.6M
Q3 24
$30.2M
$3.1B
Q2 24
$31.2M
$4.0B
Q1 24
$34.1M
$3.9B
Debt / Equity
IRIX
IRIX
SITC
SITC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
SITC
SITC
Operating Cash FlowLast quarter
$19.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.15×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
SITC
SITC
Q4 25
$19.6M
Q3 25
$-1.2M
$5.2M
Q2 25
$-397.0K
$17.2M
Q1 25
$-1.1M
$5.7M
Q4 24
$-1.2M
$112.0M
Q3 24
$-3.1M
$36.8M
Q2 24
$-1.3M
$66.5M
Q1 24
$-1.6M
$40.0M
Free Cash Flow
IRIX
IRIX
SITC
SITC
Q4 25
Q3 25
$-1.2M
Q2 25
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
IRIX
IRIX
SITC
SITC
Q4 25
Q3 25
-9.4%
Q2 25
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
IRIX
IRIX
SITC
SITC
Q4 25
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
IRIX
IRIX
SITC
SITC
Q4 25
0.15×
Q3 25
Q2 25
0.37×
Q1 25
1.86×
Q4 24
Q3 24
0.11×
Q2 24
0.28×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons